Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonhematologic Neoplasms, Advanced”

14 trials

Showing 14 of 14 results

Early research (Phase 1)Study completedNCT00677170
What this trial is testing

Study of MLN4924 in Adult Patients With Nonhematologic Malignancies

Who this might be right for
Advanced Nonhematologic Malignancies
Millennium Pharmaceuticals, Inc. 62
Early research (Phase 1)Study completedNCT01204073
What this trial is testing

TAK-441 in Adult Patients With Advanced Nonhematologic Malignancies

Who this might be right for
Advanced Nonhematologic MalignanciesCarcinoma, Basal Cell
Millennium Pharmaceuticals, Inc. 34
Early research (Phase 1)Study completedNCT00831896
What this trial is testing

Phase I Study of TAK-701 in Adult Patients With Advanced Nonhematological Malignancies

Who this might be right for
Advanced Solid Tumors
Millennium Pharmaceuticals, Inc. 27
Early research (Phase 1)Study completedNCT02412722
What this trial is testing

A Safety, Tolerability, and Pharmacokinetics Study of MLN0128 as a Single Agent and in Combination With Paclitaxel in Adults With Advanced Nonhematologic Malignancies

Who this might be right for
Non-hematologic Malignancy
Millennium Pharmaceuticals, Inc. 61
Early research (Phase 1)Study completedNCT00006086
What this trial is testing

BMS-188797 and Carboplatin in Treating Patients With Advanced Nonhematologic Cancer

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
H. Lee Moffitt Cancer Center and Research Institute
Early research (Phase 1)Study completedNCT00830869
What this trial is testing

IXAZOMIB in Adult Patients With Advanced Nonhematologic Malignancies

Who this might be right for
Advanced Non-hematologic Malignancies
Millennium Pharmaceuticals, Inc. 116
Early research (Phase 1)Study completedNCT00773929
What this trial is testing

Safety Study of TAK-593 Given Orally in Subjects With Nonhematologic Advanced Cancer

Who this might be right for
Solid Tumors
Millennium Pharmaceuticals, Inc. 60
Early research (Phase 1)WithdrawnNCT01613261
What this trial is testing

Study of TAK-733 in Combination With Alisertib in Adult Patients With Advanced Nonhematologic Malignancies

Who this might be right for
Advanced Nonhematologic Malignancies
Millennium Pharmaceuticals, Inc.
Early research (Phase 1)Study completedNCT02699749
What this trial is testing

Evaluate TAK-931 in Participants With Advanced Nonhematologic Tumors

Who this might be right for
Nonhematologic Neoplasms, Advanced
Millennium Pharmaceuticals, Inc. 80
Early research (Phase 1)Ended earlyNCT01179399
What this trial is testing

Study of Orally Administered TAK-960 in Patients With Advanced Nonhematologic Malignancies

Who this might be right for
Advanced Nonhematological Malignancies
Millennium Pharmaceuticals, Inc. 32
Early research (Phase 1)Study completedNCT01899053
What this trial is testing

A Safety and Pharmacokinetic Study of TAK-228 in Combination With TAK-117 in Adult Participants With Advanced Nonhematologic Malignancies

Who this might be right for
Advanced Nonhematologic Malignancies
Millennium Pharmaceuticals, Inc. 101
Early research (Phase 1)Study completedNCT00948467
What this trial is testing

Study of TAK-733 in Adult Patients With Advanced Nonhematologic Malignancies

Who this might be right for
Advanced Non-hematologic MalignanciesAdvanced Metastatic Melanoma
Millennium Pharmaceuticals, Inc. 51
Early research (Phase 1)Study completedNCT01454076
What this trial is testing

Pharmacokinetics Study of Oral IXAZOMIB in Participants With Advanced Nonhematologic Malignancies or Lymphoma

Who this might be right for
Nonhematologic MalignanciesLymphoma
Millennium Pharmaceuticals, Inc. 112
Early research (Phase 1)Study completedNCT02327169
What this trial is testing

A Study MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult Participants With Advanced Nonhematologic Malignancies

Who this might be right for
Advanced Nonhematologic Malignancies
Millennium Pharmaceuticals, Inc. 81

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation